MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$32,013K
Net Income
-$23,697K
Net Profit Margin
-74.02%
EPS
-$0.53
Unit: Thousand (K) dollars
Revenue Breakdown
Durable Medical Equipment Channe...
Pharmacy Benefit Plan Channel
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net sales
32,013
27,626
32,121
27,253
Cost of sales
13,111
11,189
13,177
12,134
Gross profit
18,902
16,437
18,944
15,119
Research and development
10,240
10,356
10,131
8,195
Sales and marketing
24,640
20,735
16,334
16,045
General and administrative
9,600
9,617
8,603
7,922
Total operating expenses
44,480
40,708
35,068
32,162
Loss from operations
-25,578
-24,271
-16,124
-17,043
Interest income
2,177
2,376
2,658
2,833
Other expense
-2
-
0
1
Change in fair value of warrant liabilities
0
0
0
0
Total other income (expense), net
2,175
2,376
2,658
2,834
Net loss
-23,403
-21,895
-13,466
-14,209
Unrealized loss on short-term and long-term investments
-294
-499
49
205
Comprehensive loss
-23,697
-22,394
-13,417
-14,004
Basic EPS
-0.53
-0.49
-0.302
-0.33
Diluted EPS
-0.53
-0.49
-0.302
-0.33
Basic Average Shares
44,545,293
44,436,274
44,376,777
43,634,006
Diluted Average Shares
44,545,293
44,436,274
44,376,777
43,634,006
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
ILet
$12,651K
(-5.69%↓ Y/Y)
Single Use Products
$7,762K
(48.41%↑ Y/Y)
Single Use Products
$11,379K
(159.26%↑ Y/Y)
ILet
$221K
(7.80%↑ Y/Y)
Comprehensive loss
-$23,697K
(-39.72%↓ Y/Y)
Interest income
$2,177K
(-27.55%↓ Y/Y)
Durable Medical
Equipment Channel
$20,413K
(9.49%↑ Y/Y)
Pharmacy Benefit Plan
Channel
$11,600K
(152.50%↑ Y/Y)
Net loss
-$23,403K
(-38.73%↓ Y/Y)
Unrealized loss on
short-term and long-term...
-$294K
(-223.08%↓ Y/Y)
Total other income
(expense), net
$2,175K
(-27.57%↓ Y/Y)
Net sales
$32,013K
(37.76%↑ Y/Y)
Other expense
-$2K
(0.00%↑ Y/Y)
Loss from operations
-$25,578K
(-28.71%↓ Y/Y)
Gross profit
$18,902K
(51.18%↑ Y/Y)
Cost of sales
$13,111K
(22.13%↑ Y/Y)
Total operating
expenses
$44,480K
(37.39%↑ Y/Y)
Sales and marketing
$24,640K
(57.72%↑ Y/Y)
Research and development
$10,240K
(15.41%↑ Y/Y)
General and
administrative
$9,600K
(21.84%↑ Y/Y)
Buy us a coffee
Beta Bionics, Inc. (BBNX)
Beta Bionics, Inc. (BBNX)